multiple sclerosis

https://www.news-medical.net/news/20251022/People-with-multiple-sclerosis-found-to-have-dysbiotic-oral-microbiome.aspx

Normal appearing white matter and disability in multiple sclerosis BACKGROUND AND OBJECTIVES Multiple sclerosis (MS) is characterized by lesions and atrophy on conventional MRI, yet these often fail to explain disability. Diffusion MRI (dMRI) detects microstructural injury with diffusion...

https://www.news-medical.net/news/20251107/New-method-promises-to-alleviate-the-symptoms-of-multiple-sclerosis.aspx

Characterizing post-COVID-19 syndrome in multiple sclerosis: Vaccine status, infection burden, and therapy categories as predictors Deepak Sharma ∙ Christian P. Kamm ∙ Robert Hoepner ∙ Iris-Katharina Penner ∙ Thomas Nyffeler ∙ Lara Diem [Line breaks added] Background Post-COVID-19 syndrome...

https://www.msn.com/en-gb/health/medical/biology-teacher-becomes-first-uk-patient-to-receive-gamechanger-therapy-for-ms/ar-AA1P4nc7?ocid=msedgntp&pc=U531&cvid=68fb7249618f479794914ca2e693c6df&ei=10 https://www.independent.co.uk/news/health/multiple-sclerosis-gamechanger-therapy-nhs-b2850928.html

Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis BACKGROUND AND OBJECTIVES Intrathecal synthesis of immunoglobulin G (IgG) is a key feature of multiple sclerosis (MS) and a prognostic marker for the disease course. Although previous...

Cognitive fatigue is among the most pervasive and disabling symptoms experienced by individuals with multiple sclerosis (MS), yet it remains underrecognized and undertreated in both research and clinical settings. Despite its prevalence, cognitive fatigue is often confused with general fatigue...

https://www.msn.com/en-gb/health/other/doctors-believe-they-are-on-the-brink-of-a-new-class-of-treatments-for-ms/ar-AA1NlKJc?ocid=BingNewsSerp

GWAS highlights the neuronal contribution to multiple sclerosis susceptibility https://pmc.ncbi.nlm.nih.gov/articles/PMC11643295/ Multiple Sclerosis (MS) is a chronic inflammatory and neurodegenerative disease affecting the brain and spinal cord. Genetic studies have identified many risk loci...

Key Points Question What are the patterns of health care use in the 25 years preceding the clinically determined onset of multiple sclerosis (MS)? Findings In this cohort study of 2038 patients with MS and a matched cohort of 10 182 individuals without MS, all-cause physician visits were...

https://www.news-medical.net/news/20250729/Genetic-profiling-offers-hope-for-understanding-multiple-sclerosis-risk.aspx

Effectiveness of non-pharmacological Interventions For Fatigue in Long term conditions (EIFFEL) - systematic review and network meta-analysis Joanna Leaviss, Christopher Burton, EIFFEL study group, University of Sheffield [Line breaks added] Objective To assess the clinical effectiveness of...

The phenotypic and genetic association between endometriosis and immunological diseases Nina Shigesi, Holly R Harris, Hai Fang, Anne Ndungu, Matthew R Lincoln, The International Endometriosis Genome Consortium, The 23andMe Research Team, Chris Cotsapas, Julian Knight, Stacey A Missmer, Andrew P...

Uncinate Fasciculus Lesion Burden and Anxiety in Multiple Sclerosis Erica B. Baller, Audrey C. Luo, Matthew K. Schindler, Elena C. Cooper, Margaret K. Pecsok, Matthew C. Cieslak, Melissa Lynne Martin, Amit Bar-Or, Ameena Elahi, Christopher M. Perrone, Bailey C. Spangler, Theodore D...

Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study Viktor Grut, Martin Biström, Jonatan Salzer, Pernilla Stridh, Daniel Jons, Rasmus Gustafsson, Anna Fogdell-Hahn, Jesse Huang, Nicole Brenner, Julia Butt, Noemi Bender, Anna...

Efficacy of pharmacologic treatments for fatigue in multiple sclerosis: A systematic review and meta-analysis Karlo Toljana, Albert Aboseifb, Moein Amina Highlights • Amantadine and modafinil are the most studied medications for fatigue in MS. • In a pooled analysis, medications demonstrated...

Comparative Study Between Cognitive Phenotypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Multiple Sclerosis Mehdi Aoun Sebaiti, Nadia Oubaya, Yannick Gounden, Chloé Samson, Emmanuele Lechapt, Abir Wahab, Alain Creange, Mathieu Hainselin, François-Jérôme Authier Objective...

HERV Dysregulation in a Case of Myalgic Encephalomyelitis and Multiple Sclerosis Responsive to Rituximab Eva Martín-Martínez, Sara Gil-Perotin, Karen Giménez-Orenga, Lucas Barea-Moya, Elisa Oltra [Line breaks added] Abstract This article summarizes the case of 30-year-old male diagnosed with...

Functional neurological disorder in multiple sclerosis: A prospective study Cuoco; Scannapieco; Barra; Giordano; Gregorio; Barone; Erro BACKGROUND There is increasing recognition Functional Neurological disorder (FND) is comorbid with other neurological conditions, but little is known about...

Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system (CNS), the pathophysiology of which remains unclear and for which there is no definitive cure. Antimicrobial peptides (AMPs) are immunomodulatory molecules expressed in various tissues, including the CNS...